$CSTM

Ormerod John sold $280K of CSTM

Ormerod John sold 8,000 shares of CONSTELLIUM SE (CSTM) at $35.01 ($0.28M total) on 2026-06-04.

Original reporting
SEC EDGAR · Ormerod John
Published Jun 8, 2026, 1:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 8, 2026, 1:38 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CSTM
Neutral
medium confidence
Mentioned
$CSTM
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSTMNeutralLow
01

Why it matters

Provides a fresh, dated datapoint on insider behavior for CSTM, but does not include any new company-specific fundamental catalyst.

02

Market read

Useful for monitoring insider activity, but not a standalone fundamental catalyst.

03

What to watch

No 10b5-1 plan is cited; traders may want to check whether this director has a history of clustered sales or whether other insiders filed around the same period.

Relevance 4/10Novelty 8/10Timing: filed 2026-06-08 (covers sale dated 2026-06-04)

Background

The article is a SEC Form 4 insider transaction disclosure (director selling issuer shares).

Company-level read

Ticker impact

$CSTMNeutralMedium confidence
Context

Constellium director John Ormerod filed an open-market sale of 8,000 shares at $35.01 on 2026-06-04, leaving 24,873 shares.

Expected impact

Low near-term impact; any reaction is likely noise unless follow-on filings show sustained selling.

Evidence & confidence

The filing is a primary-source insider transaction, but it is not tied to new fundamentals, guidance, or corporate actions in the article.

Market effects

No sector read-across; this is a single-company insider transaction with no operational or regulatory linkage stated.

None indicated.

None indicated.

Counterpoint

Insider sales can be tax- or diversification-driven; without a 10b5-1 plan and with a remaining large stake, the signal may be weaker than it looks.

Key entities

  • Constellium SE

    Subject of the Form 4 insider sale disclosure.

  • John Ormerod

    Director who sold 8,000 shares of CSTM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CSTMHighAI 9/10

Why is Constellium stock surging today?

Constellium (CSTM) stock rose 3.8% in pre-market trading after reporting Q3 2026 results that exceeded expectations. Adjusted EPS was $0.84 vs. $0.63 estimate, revenue was $2.6B vs. $2.2B estimate, and adjusted EBITDA hit a record $276M. The company raised its full-year adjusted EBITDA guidance to $1.03B-$1.06B and upgraded its free cash flow outlook to above $300M. Management attributed the results to strong operations and improved market dynamics.

$CSTMHighAI 8/10

Constellium shares jump 4% on strong earnings beat and raised guidance

Constellium SE (NYSE: CSTM) reported Q3 earnings of $0.84 per share, beating estimates by $0.21, with revenue up 22% YoY to $2.6B. The company raised its full-year 2026 adjusted EBITDA guidance to $1.03B-$1.06B. Shares rose 4.4% in pre-market trading. CEO Ingrid Joerg highlighted strong performance across all segments, including record EBITDA in Packaging & Automotive Rolled Products and Aerospace & Transportation.

$CSTMHigh

Constellium Reports Strong Third Quarter 2026 Results; Raises Full Year 2026 Guidance Paris - Constellium SE today reported results for the…

CONSTELLIUM SE (CSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. October 28, 2026 Constellium Reports Strong Third Quarter 2026 Results; Raises Full Year 2026 Guidance Paris - Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the third quarter and the nine months ended September 30, 2026. Third quarter 202